Please ensure Javascript is enabled for purposes of website accessibility

Cresco Labs Wins Crucial Approval for 2nd Downtown Chicago Dispensary

By Eric Volkman - Mar 9, 2020 at 8:35PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The new store will be located in the dead center of Illinois' burgeoning cannabis market.

Cresco Labs (CRLBF -2.17%) is one big step closer to opening its second dispensary in downtown Chicago. The company announced Monday that it has received special use approval from the city's zoning board of appeals for its store in the River North district.

Obtaining the zoning permit means the marijuana company has one final hurdle remaining before the dispensary, which will bear the company's Sunnyside brand name, can be granted an adult use dispensing organization license -- an inspection by the Illinois Department of Financial and Professional Regulation. If the dispensary passes the inspection and receives the license, it can open for business.

Sunnyside* dispensary in downtown Chicago.

Image source: Cresco Labs

"Earning the right to operate in this highly coveted location is both a privilege and a significant opportunity for Cresco," the company said in the press release trumpeting the news. It didn't hesitate to point out that the upcoming Sunnyside location is quite close to the Magnificent Mile, a busy Chicago shopping district.

Sunnyside is the core of Chicago-based Cresco's retail strategy. The new store will give it a total of six dispensaries in Illinois, only one of which is currently situated in Chicago proper. The company also holds licenses to open another four dispensaries, at least one of which will be located in the city.

The timing of its Illinois build-out is auspicious; marijuana companies operating in the state are reaping the benefits of a white-hot market since recreational pot legalization kicked in at the beginning of this year.

Despite the good news, Cresco's stock was dragged down by the bear market on Monday. Its shares fell by almost 19% on the day.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Cresco Labs Inc. Stock Quote
Cresco Labs Inc.
CRLBF
$2.73 (-2.17%) $0.06

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
336%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.